City

Houston (2)

Condition

Myelodysplastic Disorders (2)

AML (1)

Acute Myeloid Leukemia (1)

Leukemia (1)

Lymphoproliferative Disorders (1)

Multiple Myeloma (1)

Plasma Cell Dyscrasia (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Baylor College of Medicine (1)

M.D. Anderson Cancer Center (1)

Collaborator

Bayer (1)

Center for Cell and Gene Therapy, Baylor College of Medicine (1)

The Methodist Hospital Research Institute (1)

Intervention

ara-c (1)

campath 1h (1)

fk50 (1)

fludarabine (1)

idarubicin (1)

sorafenib (1)

stem cell collection and infusion (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

myelodysplastic disorders

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Myelodysplastic Disorders, Leukemia, Multiple Myeloma Trial in Houston (FLUDARABINE, CAMPATH 1H, FK50)

Completed

Myelodysplastic Disorders
+4 more

FLUDARABINE
+3 more

Houston, Texas
+1 more

Jan 15, 2020

AML, Acute Myeloid Leukemia, Myelodysplastic Disorders Trial in Houston (Idarubicin, Sorafenib, Ara-C)

Completed

Has Results

AML
+2 more

Idarubicin
+2 more

Houston, Texas

The University of Texas M.D. Anderson Cancer Center

Jul 23, 2018